Synthetic biology chassis: companies, startups and research

Explore the engineered cell platforms used to build biological systems, from established bacterial and yeast hosts to emerging fungi and non-model microbes. See where research, applications and technical approaches are moving.

Updated 26 October 2026Based on 14,623 documents
745
Organizations active (24 mo)
+21% activity YoY
11
Startups (young or venture-backed)
32
Funding rounds (24 mo)
$75.9B disclosed
869
Publications in 2025
+15% vs 2024

Synthetic biology chassis in 2026: overview

A synthetic biology chassis is an engineered cell or organism that hosts biological systems, such as pathways for making medicines, food ingredients or chemicals. The host shapes how reliably those systems work: its metabolism, genetic tools, growth conditions and ability to scale all affect production. Established hosts offer familiar engineering methods, while non-model organisms can bring useful traits such as strong secretion or the ability to use less conventional feedstocks. The central challenge is matching the organism to the task without sacrificing stability, yield or manufacturability.

Recent work is broadening the chassis toolkit and improving how researchers engineer it. In October 2026, Nanjing TechUniversity reported stable episomal vectors and metabolic optimization in Naematelia aurantialba for polysaccharide production. A September 2026 review from the Chinese Academy of Sciences and collaborators outlined AI-enabled fungal biomanufacturing, from genome mining toward virtual-cell models. Both directions address a persistent bottleneck: making less familiar organisms experimentally tractable, then predicting how engineered strains will perform in production. Research also spans programmable yeasts, non-model bacteria and engineered microbes for therapeutics, with growth-production balance and portable genetic tools remaining open problems.

  • 1Beyond familiar hosts: Stable episomal vectors in Naematelia aurantialba, reported by Nanjing TechUniversity in October 2026, show how genetic-tool development can bring less-established fungi into the chassis toolkit.
  • 2Models meet microbes: The Chinese Academy of Sciences and collaborators surveyed AI-enabled fungal biomanufacturing in September 2026, pointing toward computational methods that connect genome mining with chassis design.
  • 3Output versus growth: Balancing cell growth with product formation remains a core engineering constraint, shifting attention from simply increasing pathway flux toward coordinated control of cellular resources.
Summary generated from Linknovate data on 26 October 2026.

Top organizations working on synthetic biology chassis

Ranked by Linknovate activity score · last 24 months

The activity score adds up the relevance of every patent, publication, grant and news item linking an organization to synthetic biology chassis. Showing 7 of 745 organizations.

#OrganizationApproachSignals (24 mo)MomentumWhy it matters
1
Jiangnan University Research · China
Bacillus chassis PAT 4 · PUB 210 +145% Its research covers microbial chassis for ergothioneine biosynthesis and Bacillus subtilis cell factories for nutraceutical production.
2 Yeast chassis PUB 194 +46% Recently, researchers associated with CAS developed a dual-dimensional CRISPR toolkit for multiplex genome editing in Komagataella phaffii, a methanol-utilizing yeast chassis.
3 General PUB 94 +24% Its research addresses microbial chassis and strain engineering for biomanufacturing, including screening environmental microbes for ethanol tolerance and enzyme engineering for conversion of one-carbon feedstocks.
4
Tianjin University Research · China
Bacillus chassis PUB 56 · NEWS 9 +110% Its work includes synthetic biology strategies for food-grade chassis and microbial production, including biosynthesis of the α-agarofuran scaffold associated with the biopesticide Celangulin V.
5
Shandong University Research · China
Yeast chassis PAT 1 · PUB 62
NEWS 1
+137% Recently, researchers associated with the university established rDNA-mediated multicopy integration of gene clusters in Aureobasidium melanogenum, a non-conventional yeast chassis.
6
Tsinghua University Research · China
Filamentous fungi PAT 1 · PUB 50
NEWS 3
+16% Recently, researchers associated with the university used Aspergillus as a biofactory to leach and recover rare earth elements from ion-adsorption ores.
7 Yeast chassis PAT 3 · PUB 49 +0% Its research includes developing Rhodotorula red yeasts as microbial cell factories, which can accumulate lipids and serve as hosts for bioproduction.
8
··Hidden organizationCompany
ApproachPAT 00 · PUB 00
GRANTS 0 · NEWS 00
+00%Available to registered users.
9
··Hidden organizationCompany
ApproachPAT 00 · PUB 00
GRANTS 0 · NEWS 00
+00%Available to registered users.
10
··Hidden organizationCompany
ApproachPAT 00 · PUB 00
GRANTS 0 · NEWS 00
+00%Available to registered users.
+738 more organizations
Including 11 startups and 600 universities & research centers. Filter by country, approach and maturity.

Startups to watch and leading research centers

Startups to watch 11 total

Young and venture-backed companies with the highest activity score.
  • SyngensRecently, it joined a marine bioprospecting project combining AI-driven prioritization, digital twins, and predictive DNA design to identify biosynthetic potential in marine microbiomes; its research also addresses gene expression in Thermus thermophilus.
  • Lifeglimmer GmbhGermanyIts research includes Rhodo-Box, a synthetic biology toolbox for engineering Rhodobacter sphaeroides, and computational optimization of malonyl-CoA availability in Pseudomonas putida.
  • SC
    Shanghai ChangingBio Biotechnology Co. Ltd.ChinaRecently, researchers associated with the company remodeled pathways and used adaptive evolution to enable more efficient glucose and xylose co-utilization in Escherichia coli.
  • ··
    Hidden startupCountryAvailable to registered users, with funding and founding year.
  • ··
    Hidden startupCountryAvailable to registered users, with funding and founding year.
See all 11 startups, with funding and founding year

Leading research institutions 600 total

Ranked by publications, patents, grants and news in the last 24 months.
  • Jiangnan UniversityChinaIts research covers microbial chassis for ergothioneine biosynthesis and Bacillus subtilis cell factories for nutraceutical production.
  • Chinese Academy of Sciences CASChinaRecently, researchers associated with CAS developed a dual-dimensional CRISPR toolkit for multiplex genome editing in Komagataella phaffii, a methanol-utilizing yeast chassis.
  • University of Chinese Academy of SciencesChinaIts research addresses microbial chassis and strain engineering for biomanufacturing, including screening environmental microbes for ethanol tolerance and enzyme engineering for conversion of one-carbon feedstocks.
  • ··
    Hidden research institutionCountryAvailable to registered users, with their key researchers.
  • ··
    Hidden research institutionCountryAvailable to registered users, with their key researchers.
See all research groups and their key researchers

Where synthetic biology chassis innovation happens

United States
47.5%
China
30.4%
Germany
17.8%
United Kingdom
15.3%
Japan
11.6%
France
8.1%
South Korea
8.0%
India
5.9%
Italy
5.5%
Netherlands
5.1%
Rest of worldEurope

Share of documents with at least one organization from each country.

Open the interactive map with all 745 organizations

Main technical approaches

Last 24 months
ApproachWhat it isDocumentsLeading organizations
Escherichia coliA well-characterized bacterial host with versatile genetic tools; its established workflows can be less suited to products requiring traits absent from the organism. 579
Jiangnan University, Chinese Academy of Sciences CAS, Beijing University of Chemical Technology
Bacillus chassisBacillus hosts support secretion and industrial production, but strain-specific engineering and process optimization can complicate transfer between applications. 127
Jiangnan University, Chinese Academy of Sciences CAS, TianJin University of Science &Technology
Non-model bacteriaThese hosts can use distinctive metabolisms or feedstocks, but limited genetic toolsets and less predictable behavior make engineering harder. 225
Jiangnan University, Natural Science Foundation of China, Biodesign Research
Yeast chassisYeasts combine eukaryotic cell biology with established fermentation use, though each species can require tailored genetic tools and pathway engineering. 408
Chinese Academy of Sciences CAS, Jiangnan University, University of Chinese Academy of Sciences
Filamentous fungiFungi offer strong secretion and metabolic diversity, while complex growth forms and less mature engineering methods can hinder process control. 64
Chinese Academy of Sciences CAS, South China University of Technology, University of Sichuan
Plant chassisPlant cells and organisms can support biosynthesis in a native biological context, but engineering and production can be slower or more complex than microbial routes. 25
South China Agricultural University, Guangxi Normal University, East Tennessee State University

Funding and investment

$75.9B
Disclosed private funding, 32 rounds in the last 24 months
$73.8M
Public grant funding since 2020, across 61 grants
11
Startups active in the last 24 months

Recent funding rounds

Jul 2027
Astrazeneca United Kingdom
$135MExpansion
Mar 2026
U.S. Department of Energy United States
$1.9BGrant
Month 20XX
Hidden organization Country · investors
$00MSeries X
Month 20XX
Hidden organization Country · investors
$00MSeries X
See all 30 rounds, with investors and amounts

Grant data since 2020 totals $73,839,370 across 61 grants. The listed funding rounds include major expansions and financings that are not clearly dedicated to synthetic biology chassis, so they should not be treated as direct sector investment.

Patent landscape

Top patent holders · last 24 months
Contemporary Amperex Technology Co. Ltd
27
LG Corp
21
Oshkosh Corporation
13
Dell
11
New Energy Technology
10
See every patent holder and their full portfolio

Recent developments

Latest news, duplicates removed
  • Aug 2026
    The Sphere Under a fluorescence microscope in a lab at the University of Minnesota, a sphere no larger than a red blood cell glows green against a black field. Over the course of roughly an hour it narrows at its…
    Medicine on Medium
  • Aug 2026
    Boston-based Ginkgo Bioworks has teamed up with Slovenia’s Acies Bio to scale up production of enhanced Aspergillus niger strains for use in industrial-scale protein solutions. Ginkgo Bioworks is ramping up industry…
    Green Queen
  • Jul 2026
    Well, let’s see. Laat week much of the U.S. and parts of Europe were under a crippling heat dome. The U.S. celebrated its 250th birthday. And there’s something called the World Cup going on, for those of you who care…
    Science on Medium
  • Jul 2026
    A living organism is made from components that aren’t themselves living. This simple statement has profound implications. For one, it means that there is no mystical force that animates us and other life forms. For…
    New Scientist - Space
  • Month 20XX
    Hidden development
    Available to registered users with alerts enabled.
Get alerts for new synthetic biology chassis developments

Frequently asked questions about synthetic biology chassis

Which universities and research centers lead synthetic biology chassis research?

Jiangnan University and the Chinese Academy of Sciences lead the listed research activity, with 214 and 194 documents in the defined window, respectively. Other active groups include the University of Chinese Academy of Sciences, Tianjin University and Shandong University. Recent work spans Bacillus cell factories, yeast genome-editing tools and engineering of less-conventional fungal hosts.

How much funding has synthetic biology chassis received?

The recorded grant total is $73,839,370 across 61 grants since 2020. This figure describes the grant data associated with the topic, not necessarily investment exclusively for chassis development. Funding-round entries also include expansions and financings that do not clearly concern chassis engineering, so they are not a reliable measure of dedicated commercial investment.

Who holds the most synthetic biology chassis patents?

The listed patent holders include Contemporary Amperex Technology Co. Ltd with 27 patents and LG Corp with 21. Other names include Oshkosh Corporation and Dell. These are the patent-holder entries associated with this topic dataset; the names and counts should be checked against individual patent records before drawing conclusions about specific chassis technologies or commercial ownership.

Is synthetic biology chassis patent activity growing?

Patent activity is down 40.1% in the defined comparison of the last 12 months with the previous 12 months, with 323 patents in the 24-month window. Publications moved in the opposite direction: 869 were recorded in 2025, up 14.6% from the prior year. This divergence suggests continued research activity alongside a weaker recent patent trend.

How mature is synthetic biology chassis?

The field combines established hosts with early-stage work on less conventional organisms: 869 publications were recorded in 2025, while patent activity fell 40.1% in the latest 12-month comparison. E. coli and yeast have substantial engineering histories, but newer fungal and non-model bacterial chassis still need better genetic tools, predictable performance and robust production processes.

What are the latest developments in synthetic biology chassis?

Recent developments include Naematelia aurantialba vector construction and metabolic optimization by Nanjing TechUniversity in October 2026, and an AI-enabled fungal biomanufacturing review from the Chinese Academy of Sciences and collaborators in September 2026. These efforts address genetic accessibility and computational prediction, both important for extending engineering beyond familiar model organisms.

What new methods or terms are emerging in synthetic biology chassis?

Metabolic engineering is a prominent emerging term, with 202 documents in the topic data. Recent methods include stable episomal vectors for Naematelia aurantialba, multiplex CRISPR editing in Komagataella phaffii, and AI approaches linking fungal genome mining with virtual-cell models. The common direction is to make chassis easier to edit and their production behavior easier to predict.

What are the main approaches in synthetic biology chassis, and how do they differ?

The tracked approaches include E. coli, Bacillus, non-model bacteria, yeast, filamentous fungi and plant chassis. E. coli and yeast benefit from established engineering workflows; Bacillus and fungi can offer useful production traits such as secretion. Non-model organisms may use distinctive feedstocks or metabolisms, but typically need more host-specific genetic tools and process development.

What are the applications of synthetic biology chassis?

The listed applications include pharmaceuticals and therapeutics, with 394 documents; chemicals and materials, with 182; food and alternative proteins, with 176; environmental applications, with 109; and agriculture, with 65. Examples include microbial production of therapeutic compounds, food ingredients and platform chemicals, as well as engineered organisms for environmental and agricultural uses.

Go beyond the top 7

Discover and track organizations, patents, publications, grants, news and more. Get live alerts on new startups, funding rounds and emerging developments.